Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Fabian, Maass"'
Autor:
Lars Tatenhorst, Fabian Maass, Hannah Paul, Vivian Dambeck, Mathias Bähr, Rosanna Dono, Paul Lingor
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract Glypicans are biomarkers for various pathologies, including cardiovascular disease, cancer and diabetes. Increasing evidence suggests that glypicans also play a role in the context of neurodegenerative disorders. Initially described as suppo
Externí odkaz:
https://doaj.org/article/a8954727db2f4ec38e07fd7bba1622d8
Autor:
Sebastian Johannes Müller, Eya Khadhraoui, Niels Hansen, Ala Jamous, Philip Langer, Jens Wiltfang, Christian Heiner Riedel, Caroline Bouter, Christoph van Riesen, Fabian Maass, Michael Bartl, Claudia Lange, Marielle Ernst
Publikováno v:
BMC Neurology, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Although Dementia with Lewy bodies (DLB) is the second most common form of dementia in elderly patients, it remains underdiagnosed compared with Alzheimer's (AD) and Parkinson's diseases (PD). This may be explained by overlapping
Externí odkaz:
https://doaj.org/article/12afb2514bb849bcbca9e616bd0ff8f2
Autor:
Fabian Maass, Peter Hermann, Daniela Varges, Sabine Nuhn, Christoph van Riesen, Ala Jamous, Niels K. Focke, Manuel Hewitt, Andreas Leha, Mathias Bähr, Inga Zerr
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
The objective of the study was to characterize the pattern of cognitive dysfunction in patients with multiple system atrophy (MSA) applying a standardized neuropsychological assessment. A total of 20 patients with the diagnosis of probable or possibl
Externí odkaz:
https://doaj.org/article/b855f299e40348ecb0234244350a1c51
Autor:
Lucas Caldi Gomes, Ana Galhoz, Gaurav Jain, Anna‐Elisa Roser, Fabian Maass, Eleonora Carboni, Elisabeth Barski, Christof Lenz, Katja Lohmann, Christine Klein, Mathias Bähr, André Fischer, Michael P. Menden, Paul Lingor
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 1, Pp n/a-n/a (2022)
Abstract Background Parkinson's disease (PD) is the second most common neurodegenerative disorder whose prevalence is rapidly increasing worldwide. The molecular mechanisms underpinning the pathophysiology of sporadic PD remain incompletely understoo
Externí odkaz:
https://doaj.org/article/c1c958499e774a69ba69e7f59eb3c227
Autor:
Sezgi Canaslan, Matthias Schmitz, Anna Villar-Piqué, Fabian Maass, Karin Gmitterová, Daniela Varges, Paul Lingor, Franc Llorens, Peter Hermann, Inga Zerr
Publikováno v:
Frontiers in Aging Neuroscience, Vol 13 (2021)
Alpha-synucleinopathies, such as Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA), are a class of neurodegenerative diseases. A diagnosis may be challenging because clinical symptoms partially overlap, an
Externí odkaz:
https://doaj.org/article/12ebdbded9104708ae455bb953c171ba
Autor:
Lucas Caldi Gomes, Anna‐Elisa Roser, Gaurav Jain, Tonatiuh Pena Centeno, Fabian Maass, Lukas Schilde, Caroline May, Anja Schneider, Mathias Bähr, Katrin Marcus, André Fischer, Paul Lingor
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 4, Pp n/a-n/a (2021)
Externí odkaz:
https://doaj.org/article/c151f27825af4db1ada11e723cb80efa
Autor:
Fabian Maass, Philipp von Gottberg, Jonas Franz, Christine Stadelmann, Mathias Bähr, Martin S. Weber
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Fingolimod represents a highly effective disease-modifying drug in patients with active relapsing-remitting multiple sclerosis (RRMS). Its immunosuppressive effects can mediate adverse events like increased risk of cancer development or appearance of
Externí odkaz:
https://doaj.org/article/dbbfd4dc4c604d61b2f27676f62413ca
Autor:
Anna Emdina, Peter Hermann, Daniela Varges, Sabine Nuhn, Stefan Goebel, Timothy Bunck, Fabian Maass, Matthias Schmitz, Franc Llorens, Niels Kruse, Paul Lingor, Brit Mollenhauer, Inga Zerr
Publikováno v:
Diagnostics, Vol 12, Iss 5, p 1259 (2022)
Biomarkers are increasingly recognized as tools in the diagnosis and prognosis of neurodegenerative diseases. No fluid biomarker for Parkinson’s disease (PD) has been established to date, but α-synuclein, a major component of Lewy bodies in PD and
Externí odkaz:
https://doaj.org/article/fcc6fee58f04472db82ed89ca1764fc1
Autor:
Lukas M. Schilde, Simone Steinbach, Bettina Serschnitzki, Fabian Maass, Mathias Bähr, Paul Lingor, Katrin Marcus, Caroline May
Publikováno v:
Data in Brief, Vol 32, Iss , Pp 106048- (2020)
Spectral libraries generated by data dependent acquisition (DDA) are a useful tool for the analysis of data created by data independent acquisition (DIA) in mass spectrometry. The quality of DIA analysis is dependent on the quality of the spectral li
Externí odkaz:
https://doaj.org/article/df343fe76c0d475098db413630a0e4c9
Compassionate Use of the ROCK Inhibitor Fasudil in Three Patients With Amyotrophic Lateral Sclerosis
Autor:
Jan C. Koch, Josua Kuttler, Fabian Maass, Teresa Lengenfeld, Eirini Zielke, Mathias Bähr, Paul Lingor
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
The Rho kinase (ROCK) inhibitor Fasudil is a promising drug for a disease-modifying therapy of amyotrophic lateral sclerosis (ALS). In preclinical models, Fasudil was shown to increase motor neuron survival, inhibit axonal degeneration, enhance axona
Externí odkaz:
https://doaj.org/article/9965977abcc847f383c790d1dbd168fb